Las Vegas—The short-acting experimental benzodiazepine remimazolam performed impressively in outpatient colonoscopy, with rapid-onset sedation and far faster recovery than midazolam, according to results from a Phase III trial.
Although the double-blind comparison was made with placebo, the time to sedation and time to recovery with remimazolam (Paion) were remarkably fast, the investigators reported: 54% faster than midazolam in an open-label comparison of the two drugs that was part of